[PDF][PDF] 西妥昔单抗联合化疗或放疗治疗晚期头颈鳞癌的疗效评价
李金忠， 郑家伟， 张志愿 - 上海口腔医学, 2008 - sjos.cn
… In their phase II clinical trial, 76 patients (n^76) with … /fluorouracil, received combination
therapy with cetuximab and cisplatin. The protocol was subsequently amended to enroll patients …
therapy with cetuximab and cisplatin. The protocol was subsequently amended to enroll patients …
局部晚期头颈部鳞状细胞癌的化疗及靶向进展
卫亚楠， 陈曦 - 山东大学耳鼻喉眼学报, 2021 - ebhyxbwk.njournal.sdu.edu.cn
… In 2006, cetuximab(CET)was approved by the US Food and Drug Administration for clinical
use. Because of its advantages in terms of prognosis and less side effects, CET offers a new …
use. Because of its advantages in terms of prognosis and less side effects, CET offers a new …
抗EGFR 单抗治疗复发/转移性头颈部鳞状细胞癌临床共识(2021 年版)
郭晔， 张陈平 - 中国癌症杂志, 2021 - china-oncology.com
… , docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line
treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC …
treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC …
抗EGFR 单抗治疗局部晚期头颈部鳞状细胞癌临床共识(2023 年版)
许婷婷， 胡超苏， 李宝生 - 中国癌症杂志, 2023 - china-oncology.com
… For those who received induction chemotherapy with the purpose of tumor downstaging or …
+5-fluorouracil) scheme. TPE scheme, using cetuximab as a substitution for fluorouracil, is an …
+5-fluorouracil) scheme. TPE scheme, using cetuximab as a substitution for fluorouracil, is an …
[HTML][HTML] 局部晚期下咽癌-基于放化疗的不同器官功能保留治疗模式的比较
罗希， 孙士然， 徐艺， 黄晓东， 王凯… - … , Head, and Neck …, 2023 - ncbi.nlm.nih.gov
… If the response reached complete response or partial response(more than 80% tumor
regression), patients received radical RT or CCRT; otherwise, they received surgery, if possible, at …
regression), patients received radical RT or CCRT; otherwise, they received surgery, if possible, at …
复发/转移性头颈部鳞癌免疫检查点抑制剂治疗专家共识(2024 年版)
郭晔， 张陈平 - 中国癌症杂志, 2024 - china-oncology.com
… cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer
(… Platinumbased chemotherapy plus cetuximab in head and neck cancer [J]. N Engl J Med, …
(… Platinumbased chemotherapy plus cetuximab in head and neck cancer [J]. N Engl J Med, …
救治性手术联合放疗与化疗序贯免疫检查点抑制剂治疗复发转移舌鳞癌1 例报道
丁继平， 李晓光， 刘忠龙， 邓刚， 姚原… - 上海交通大学学报(医学 …, 2021 - xuebao.shsmu.edu.cn
… with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front … cetuximab
with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (…
with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (…
[HTML][HTML] 传统抗肿瘤药物的临床应用现状与发展
徐焦， 蒙凌华， 卿晨 - 药学学报, 2021 - html.rhhz.net
… 宫颈癌是仅次于乳腺癌的第二大女性生殖系统恶性肿瘤, 以顺铂或顺铂联合氟尿嘧啶(fluorouracil,
5-FU) 为基础的放化疗是初治Ⅰb2~Ⅳa期宫颈癌的标准治疗方案, 患者的5年生存率约60%~…
5-FU) 为基础的放化疗是初治Ⅰb2~Ⅳa期宫颈癌的标准治疗方案, 患者的5年生存率约60%~…